{"component": "definition", "props": {"groups": [{"samples": [{"hash": "1IctskcpN4f", "uri": "https://www.legislature.mi.gov/documents/2015-2016/publicact/htm/2016-PA-0249.htm", "label": "www.legislature.mi.gov", "score": 10.1704311371, "published": false}, {"hash": "bM0QoaqPzGC", "uri": "https://www.legislature.mi.gov/documents/2015-2016/publicact/htm/2015-PA-0085.htm", "label": "www.legislature.mi.gov", "score": 10.1704311371, "published": false}, {"hash": "dG5i6Zv92Ix", "uri": "https://www.legislature.mi.gov/(S(yv0fidasuc1sbl42f3hovyvi))/documents/2009-2010/journal/house/pdf/2009-HJ-09-23-077.pdf", "label": "www.legislature.mi.gov", "score": 10.1704311371, "published": false}], "snippet_links": [{"key": "tuition-incentive", "type": "clause", "offset": [28, 45]}, {"key": "assistance-program", "type": "clause", "offset": [46, 64]}, {"key": "period-of", "type": "definition", "offset": [89, 98]}, {"key": "term-credits", "type": "definition", "offset": [118, 130]}, {"key": "associate-degree", "type": "clause", "offset": [155, 171]}], "size": 56, "snippet": "means the first part of the tuition incentive assistance program defined as the academic period of 80 semester or 120 term credits, or less, leading to an associate degree or certificate.", "hash": "745d20e81f8f62214cf2061d75c08212", "id": 1}, {"samples": [{"hash": "kQwsPGw8YsX", "uri": "/contracts/kQwsPGw8YsX#phase-i", "label": "Merger Agreement (QNB Corp.)", "score": 36.7262153625, "published": true}, {"hash": "jC7DNEOxi8g", "uri": "/contracts/jC7DNEOxi8g#phase-i", "label": "Merger Agreement (QNB Corp.)", "score": 36.7262153625, "published": true}, {"hash": "guJ1RwfsO7K", "uri": "/contracts/guJ1RwfsO7K#phase-i", "label": "Merger Agreement (Penns Woods Bancorp Inc)", "score": 35.967830658, "published": true}], "snippet_links": [], "size": 43, "snippet": "has the meaning set forth in Section 6.19.", "hash": "cec2b167c7669c74f8cfe8a44575223b", "id": 2}, {"samples": [{"hash": "1dBgTGQXFvw", "uri": "/contracts/1dBgTGQXFvw#phase-i", "label": "License and Collaboration Agreement (Spring Bank Pharmaceuticals, Inc.)", "score": 31.7460651398, "published": true}, {"hash": "jgKYY1nVrkl", "uri": "/contracts/jgKYY1nVrkl#phase-i", "label": "Gamma Ip Licence Agreement (Denali Therapeutics Inc.)", "score": 29.9281311035, "published": true}, {"hash": "44BESfSO611", "uri": "/contracts/44BESfSO611#phase-i", "label": "Gamma Ip Licence Agreement (Denali Therapeutics Inc.)", "score": 29.6023273468, "published": true}], "snippet_links": [{"key": "human-clinical-trial", "type": "definition", "offset": [8, 28]}, {"key": "licensed-product", "type": "definition", "offset": [34, 50]}, {"key": "purpose-of", "type": "clause", "offset": [66, 76]}, {"key": "determination-of", "type": "clause", "offset": [100, 116]}, {"key": "clinical-study", "type": "definition", "offset": [238, 252]}, {"key": "regulatory-authorities", "type": "clause", "offset": [271, 293]}, {"key": "as-amended", "type": "definition", "offset": [353, 363]}], "size": 38, "snippet": "means a human clinical trial of a Licensed Product, the principal purpose of which is a preliminary determination of safety, tolerability, dosing, pharmacological activity or pharmacokinetics in healthy individuals or patients or similar clinical study prescribed by the Regulatory Authorities, including the trials referred to in 21 C.F.R. \u00a7312.21(a), as amended.", "hash": "b57c6ee00d85b20c36567b44bffd77f9", "id": 3}, {"samples": [{"hash": "3p9XxrXwS71", "uri": "/contracts/3p9XxrXwS71#phase-i", "label": "CMRS Interconnection Agreement", "score": 36.2779769897, "published": true}, {"hash": "SaedQ5l3l1", "uri": "/contracts/SaedQ5l3l1#phase-i", "label": "Telecommunications", "score": 34.9460220337, "published": true}, {"hash": "e933HCW8LO8", "uri": "/contracts/e933HCW8LO8#phase-i", "label": "Peering Agreement", "score": 34.0557785034, "published": true}], "snippet_links": [{"key": "call-back-number", "type": "definition", "offset": [58, 74]}], "size": 36, "snippet": "as defined in CC Docket 94-102. Phase I data includes the Call Back Number and the associated 911 ALI.", "hash": "5ea8f2453041ff3a4ced21eb90634fe3", "id": 4}, {"samples": [{"hash": "iiVzt4tjr3Q", "uri": "/contracts/iiVzt4tjr3Q#phase-i", "label": "Merger Agreement (Mutualfirst Financial Inc)", "score": 30.8261470795, "published": true}, {"hash": "gusNGBnSkkX", "uri": "/contracts/gusNGBnSkkX#phase-i", "label": "Merger Agreement (First Guaranty Bancshares, Inc.)", "score": 28.0910339355, "published": true}, {"hash": "9Ynq7SJ63cm", "uri": "/contracts/9Ynq7SJ63cm#phase-i", "label": "Merger Agreement (First Guaranty Bancshares, Inc.)", "score": 28.0800819397, "published": true}], "snippet_links": [{"key": "section-632", "type": "clause", "offset": [36, 49]}], "size": 34, "snippet": "shall have the meaning set forth in Section 6.3.2.", "hash": "4331bcc0eade5918a32e7e595b7a5b16", "id": 5}, {"samples": [{"hash": "lcjuGx2xQTW", "uri": "/contracts/lcjuGx2xQTW#phase-i", "label": "Mortgage Loan Purchase, Sale & Servicing Agreement (Structured Asset Sec Corp Mort Pas THR Cert Ser 2002 4h)", "score": 18.0, "published": true}, {"hash": "lUHGOuCo803", "uri": "/contracts/lUHGOuCo803#phase-i", "label": "Mortgage Loan Flow Purchase, Sale & Servicing Agreement (Merrill Lynch Mortgage Investors Trust Series 2005-A8)", "score": 18.0, "published": true}, {"hash": "lRqDZfDJ2fm", "uri": "/contracts/lRqDZfDJ2fm#phase-i", "label": "Mortgage Loan Flow Purchase, Sale & Servicing Agreement (Merrill Lynch Alternative Note Asset Trust, Series 2007-A1)", "score": 18.0, "published": true}], "snippet_links": [{"key": "mortgaged-property", "type": "definition", "offset": [30, 48]}, {"key": "prepared-by", "type": "clause", "offset": [49, 60]}, {"key": "independent-person", "type": "clause", "offset": [64, 82]}, {"key": "environmental-assessments", "type": "clause", "offset": [106, 131]}, {"key": "required-by", "type": "definition", "offset": [169, 180]}, {"key": "applicable-law", "type": "definition", "offset": [181, 195]}, {"key": "years-experience", "type": "definition", "offset": [209, 225]}], "size": 27, "snippet": "environmental assessment of a Mortgaged Property prepared by an Independent Person who regularly conducts environmental assessments and who has any necessary license(s) required by applicable law and has five years experience in conducting environmental assessments.", "hash": "ab369da4f2de30d2226b3773615f67b5", "id": 6}, {"samples": [{"hash": "e3SlsGPyaFK", "uri": "/contracts/e3SlsGPyaFK#phase-i", "label": "Collaboration Agreement (Ambit Biosciences Corp)", "score": 24.2361392975, "published": true}, {"hash": "cdgtbWnsvw5", "uri": "/contracts/cdgtbWnsvw5#phase-i", "label": "Collaboration Agreement (Ambit Biosciences Corp)", "score": 23.967830658, "published": true}, {"hash": "8jXfCFSulgc", "uri": "/contracts/8jXfCFSulgc#phase-i", "label": "Collaboration Agreement (Ambit Biosciences Corp)", "score": 21.8432579041, "published": true}], "snippet_links": [{"key": "phase-iii-clinical-trials", "type": "definition", "offset": [94, 119]}, {"key": "each-case", "type": "definition", "offset": [138, 147]}, {"key": "as-prescribed", "type": "definition", "offset": [148, 161]}, {"key": "rules-or-regulations", "type": "definition", "offset": [236, 256]}], "size": 24, "snippet": "\u201cPhase II\u201d and \u201cPhase III\u201d shall mean Phase I (or Phase I/II), Phase II (or Phase II/III) and Phase III clinical trials, respectively, in each case as prescribed by applicable FDA IND Regulations, or any corresponding foreign statutes, rules or regulations.", "hash": "1fffdca9e4a73eedab17862906f3dc96", "id": 7}, {"samples": [{"hash": "b2KPJfzQUrg", "uri": "/contracts/b2KPJfzQUrg#phase-i", "label": "Indenture (STUDIO CITY INTERNATIONAL HOLDINGS LTD)", "score": 29.6817245483, "published": true}, {"hash": "Pqpf7C82Bf", "uri": "/contracts/Pqpf7C82Bf#phase-i", "label": "Amendment and Restatement Agreement (STUDIO CITY INTERNATIONAL HOLDINGS LTD)", "score": 29.6817245483, "published": true}, {"hash": "3x4ESxRSUnP", "uri": "/contracts/3x4ESxRSUnP#phase-i", "label": "Indenture (STUDIO CITY INTERNATIONAL HOLDINGS LTD)", "score": 29.6817245483, "published": true}], "snippet_links": [{"key": "the-site", "type": "clause", "offset": [60, 68]}, {"key": "food-and-beverage-outlets", "type": "clause", "offset": [122, 147]}, {"key": "and-other-facilities", "type": "clause", "offset": [174, 194]}], "size": 22, "snippet": "means the approximate 477,100 gross square meter complex on the Site which contains retail, hotel, gaming, entertainment, food and beverage outlets and entertainment studios and other facilities.", "hash": "359642d876c17ef4c489c7b3c5707de2", "id": 8}, {"samples": [{"hash": "bqosGeOwG77", "uri": "/contracts/bqosGeOwG77#phase-i", "label": "Collaboration Agreement (Genvec Inc)", "score": 18.0, "published": true}, {"hash": "1lyezlJtZJr", "uri": "/contracts/1lyezlJtZJr#phase-i", "label": "Collaboration Agreement (Genvec Inc)", "score": 18.0, "published": true}, {"hash": "1cn2lLIysHi", "uri": "/contracts/1cn2lLIysHi#phase-i", "label": "Collaboration Agreement (Genvec Inc)", "score": 18.0, "published": true}], "snippet_links": [{"key": "phase-iii-clinical-trials", "type": "definition", "offset": [95, 120]}, {"key": "each-case", "type": "definition", "offset": [139, 148]}, {"key": "as-prescribed", "type": "definition", "offset": [149, 162]}, {"key": "rules-or-regulations", "type": "definition", "offset": [264, 284]}, {"key": "in-the-territory", "type": "clause", "offset": [285, 301]}], "size": 20, "snippet": "PHASE II\", and \"PHASE III\" shall mean Phase I (or Phase I/II), Phase II (or Phase II/III), and Phase III clinical trials, respectively, in each case as prescribed by the Japanese equivalent of applicable FDA IND regulations, or any corresponding foreign statutes, rules or regulations in the Territory.", "hash": "2cc58f531e3b61080287fcec2f064380", "id": 9}, {"samples": [{"hash": "6PFfkula3Mq", "uri": "https://www.legislature.mi.gov/documents/mcl/pdf/mcl-94-1979-III.pdf", "label": "www.legislature.mi.gov", "score": 19.5582313538, "published": false}, {"hash": "4FPeW7bT6Na", "uri": "http://www.legislature.mi.gov/(S(dphjwkdt4i4pub4phnrjm3l1))/documents/2021-2022/Journal/Senate/pdf/2021-SJ-09-22-072.pdf", "label": "www.legislature.mi.gov", "score": 10.9014377594, "published": false}, {"hash": "8Tm3mEE0yo2", "uri": "http://www.legislature.mi.gov/documents/2021-2022/publicact/pdf/2021-PA-0086.pdf", "label": "www.legislature.mi.gov", "score": 10.8891172409, "published": false}], "snippet_links": [{"key": "tuition-incentive-program", "type": "clause", "offset": [28, 53]}, {"key": "period-of", "type": "definition", "offset": [78, 87]}, {"key": "term-credits", "type": "definition", "offset": [107, 119]}, {"key": "an-associate", "type": "clause", "offset": [141, 153]}, {"key": "students-must", "type": "clause", "offset": [177, 190]}, {"key": "associate-degree-program", "type": "definition", "offset": [223, 247]}, {"key": "taking-classes", "type": "clause", "offset": [252, 266]}, {"key": "program-of-study", "type": "definition", "offset": [278, 294]}], "size": 19, "snippet": "means the first part of the tuition incentive program defined as the academic period of 80 semester or 120 term credits, or less, leading to an associate degree or certificate. Students must be enrolled in a certificate or associate degree program and taking classes within the program of study for a certificate or associate degree. Tuition will not be covered for courses outside of a certificate or associate degree program.", "hash": "e3e22baf9e4d04633620045fa6c2ce20", "id": 10}], "next_curs": "ClQSTmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjALEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIQcGhhc2UtaSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "Phase I", "size": 1318, "snippet": "means the first part of the tuition incentive assistance program defined as the academic period of 80 semester or 120 term credits, or less, leading to an associate degree or certificate.", "id": "phase-i", "examples": ["Either Party may terminate <strong>Phase I</strong> upon written notice if the other Party commits a Material Breach and fails to cure such breach within thirty (30) days following written notice.", "For avoidance of doubt: There shall be no independent valuation buyout mechanism applicable to <strong>Phase I</strong>.", "During <strong>Phase I</strong>, any EU-based engineering or industrialization activities shall be coordinated under Nuburu supervision and may involve Tekne pursuant to the Network Contract.", "Within thirty (30) days after the Effective Date, Borrower shall deliver to Lender (i) executed copies of comfort letters by and among each Franchisor, \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587, and Lender, (ii) the final <strong>Phase I</strong>, Property Condition Report, Property Condition Assessment for the Park City Project, and (iii) executed copies of the Assignment And Subordination Of Management Agreement And Waiver Of Management Liens by and among Borrower, Manager and Lender for each Project.", "In the event that M\u2587\u2587\u2587\u2587\u2587\u2019\u2587 forty percent (40%) interest in <strong>Phase I</strong> IP is transferred to Nuburu pursuant to Section 10.2.2 (Conditional Forfeiture), M\u2587\u2587\u2587\u2587\u2587 hereby grants to Nuburu, effective automatically upon such transfer, a perpetual, irrevocable, non-exclusive, worldwide, royalty-free license under any M\u2587\u2587\u2587\u2587\u2587 Background IP to the extent, and only to the extent, that such Background IP is necessary to use, reproduce, modify, manufacture, market, sell, license, or otherwise exploit the <strong>Phase I</strong> IP.", "If <strong>Phase I</strong> Deadlock remains unresolved after escalation under Article 7.2: Nuburu may terminate <strong>Phase I</strong> in its sole discretion.", "Either Party may terminate <strong>Phase I</strong> immediately upon written notice if the other Party: \uf0b7 Files for bankruptcy; \uf0b7 Becomes insolvent; \uf0b7 Makes a general assignment for the benefit of creditors; \uf0b7 Is subject to appointment of receiver or similar proceeding.", "All <strong>Phase I</strong> IP must be documented in sufficient detail to: \uf0b7 Support patent filings; \uf0b7 Meet enablement standards; \uf0b7 Support trade secret protection; \uf0b7 Comply with defense audit standards.", "Continue <strong>Phase I</strong> in accordance with its proposed course of action; ii.", "Maddox shall have no right to use <strong>Phase I</strong> IP except as expressly permitted."], "related": [["phase-ii", "Phase II", "Phase II"], ["phase-i-environmental-assessment", "Phase I Environmental Assessment", "<strong>Phase I</strong> Environmental Assessment"], ["phase-1", "Phase 1", "Phase 1"], ["phase-i-assessment", "Phase I assessment", "<strong>Phase I</strong> assessment"], ["phase-i-environmental-report", "Phase I Environmental Report", "<strong>Phase I</strong> Environmental Report"]], "related_snippets": [], "updated": "2026-05-21T04:35:46+00:00"}, "json": true, "cursor": ""}}